NR1H4 and relapsing-remitting multiple sclerosis: Moreover, it was further demonstrated that the expression of the bile acid receptor farnesoid X receptor (FXR), which typically confers anti-inflammatory effects, on peripheral immune cells is reduced in RRMS patients [113].